Mulas, Olga http://orcid.org/0000-0002-7487-3328
Caocci, Giovanni http://orcid.org/0000-0002-6585-5187
Efficace, Fabio
Piras, Eugenia
Targhetta, Clara
Frau, Veronica
Barella, Susanna
Piroddi, Antonio
Orofino, Maria Grazia
Vacca, Adriana
La Nasa, Giorgio
Article History
Received: 15 June 2022
Revised: 31 August 2022
Accepted: 1 September 2022
First Online: 16 September 2022
Competing interests
: FE: consultancy fees from Amgen, Abbvie, Janssen, and Novartis. Research support (Institution) from Abbvie, Amgen, Novartis, all unrelated to this work. The other authors have no competing interests to disclose.